BRIEF-FDA approves Biogen Idec's Tecfidera for Multiple Sclerosis
March 27 (Reuters) - U.S. Food and Drug Administration:
* FDA says approved Biogen idec's tecfidera (dimethyl fumarate)
capsules to treat adults with relapsing forms of Multiple Sclerosis
* Source text for Eikon:
* Further company coverage ((Bangalore Newsroom; +1 646 223 8780))
March 27- U.S. Food and Drug Administration:. *FDA says approved Biogen idec's tecfidera. capsules to treat adults with relapsing forms of Multiple Sclerosis.